Login to Your Account

Novexel Begins Phase I Trial, Gathers In Milestone Payment

By James Etheridge

Wednesday, October 12, 2005
PARIS - Novexel, a specialty pharmaceutical company, initiated a multidose Phase I trial of NXL 103, an orally administered antibiotic for the treatment of bacterial respiratory infections. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription